Described herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive medications, these types of devices like a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxygen and compr